PCSK9 and 6-month Left Ventricular Ejection Fraction after ST-segment Elevation Myocardial Infarction. A Pilot Study.

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Julio Nunez Villota

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

11 More presentations in this session

Presentation thumbnail

Plasma Indoleamine 2,3-dioxygenase is highly predictive of cardiac remodeling after myocardial infarction

Miss M. Saadi (Arcueil, FR)

Abstract Slides

Presentation thumbnail

Circulating long non-coding RNA ENST00000507296 is a prognostic indicator in patients with dilated cardiomyopathy

Doctor X. Zhang (Wu Han, CN)

Presentation thumbnail

Prognostic significance of carboxy-terminal telopeptide (ICTP) and Caspase-3 in patients with non-ischemic dilated cardiomyopathy.

Mrs I. Kazukauskiene (Klaipeda, LT)

Abstract Slides

Presentation thumbnail

Enzymatic regulation of the myocardial tissue renin-angiotensin-system of the failing heart

Doctor H. Arfsten (Vienna, AT)

Presentation thumbnail

Neurohumoral regulation of the low-, medium- and high-renin HFrEF phenotypes

Doctor S. Prausmueller (Vienna, AT)

Access the full session

Session thumbnail

Poster Session 6 - Biomarkers in heart failure

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Left ventricular reverse remodeling in heart failure with reduced ejection fraction: determinants and outcomes in a multidisciplinary heart failure clinic in a resource limited setting

Congress Presentation

New paradigms in pathological mechanosensing

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources